Catalyst Wire Dossier Catalyst Wire Dossier

AC-T

doxorubicin, cyclophosphamide, paclitaxel · Not specified
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC-T, covering 2019-03-21 to 2019-03-21. Get the full timeline:

Most recent: Clinical Trial Update: The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency [Phase 3]

See pricing